Press Releases

Arch Therapeutics, Inc. $6.1 Million Registered Direct Offering
Arch Therapeutics Provides Corporate Milestone Update, Including Anticipated Filing of 510(k) for AC5(TM)
Arch Therapeutics to Provide Corporate Updates at Two Conferences in New York, February 2017
Arch Therapeutics Announces Issuance of Method-of-Use Patent Covering Self-Assembling Peptidomimetics
Arch Therapeutics to Present at Noble Financial Capital Markets' Thirteenth Annual Equity Conference
Arch Therapeutics to Present at The Biotech Showcase(TM) 2017 Conference on January 10th, 2017
Arch Therapeutics to Present at 9th Annual LD Micro Main Event on December 7, 2016
Arch Therapeutics Reports AC5 Topical Hemostatic Device Successfully Stopped Bleeding in Patients on Antiplatelet Therapy in Recently Completed Clinical Study
Arch Therapeutics Will Present at the 2016 Bio Investor Forum in San Francisco, California October 18-19th, 2016
Arch Therapeutics Will Present at the 2016 Aegis Capital Growth Conference in Las Vegas, NV September 20-22, 2016
RSS
Show All